Vivo Capital, LLC Portfolio Holdings
Vivo Capital, LLC
- $512 Million
- Q4 2024
Vivo Capital, LLC has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $512 Million distributed in 40 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $106M, Geron Corp with a value of $96.4M, Terns Pharmaceuticals, Inc. with a value of $38.5M, Dyne Therapeutics, Inc. with a value of $26.3M, and Aclaris Therapeutics, Inc. with a value of $22M.
Examining the 13F form we can see an decrease of $171M in the current position value, from $683M to 512M.
Vivo Capital, LLC is based out at Palo Alto, CA
Below you can find more details about Vivo Capital, LLC portfolio as well as his latest detailed transactions.